Healthcare

Post-Bariatric Hypoglycemia Market to Register Stunning Growth at a 16.4% CAGR Through 2036 Owing to the Emergence of Novel Drug Classes Such as GLP-1 Receptor Antagonists, SGLT1 Inhibitors, CRH Inhibitors, and SSTR5 Agonists | DelveInsight

LAS VEGAS, July 7, 2026, 10:31 GMT-04

DELVE-INSIGHT

Read full article →

Medical Equipment Cooling Market worth $0.84 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., July 7, 2026, 10:15 GMT-04

MARKETSANDMARKETS

Read full article →

Gene Editing Market to Reach US$30.5 Billion by 2033 as Precision Medicine and CRISPR Innovation Accelerate Growth - Persistence Market Research

LONDON, July 7, 2026, 10:01 GMT-04

Persistence-Market

Read full article →

Ortho Consulting Group (OCG) partners with Life+Limb Primary Trauma Care Foundation to advance global trauma care through education

NEWBURY, England, July 7, 2026, 05:00 GMT-04

Ortho-Consulting

Read full article →

ESHRE 42nd Annual Meeting: Halving fertility treatment costs could more than double births, major global study shows

LONDON, July 6, 2026, 19:01 GMT-04

ESHRE

Read full article →

AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulatory Agency and Health Canada

LONDON, July 6, 2026, 17:49 GMT-04

AMO-Pharma-Limited

Read full article →

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

NORTH CHICAGO, Ill., July 6, 2026, 13:45 GMT-04

AbbVie-TEPKINLY

Read full article →

Global Neurotechnology Market is Projected to Cross USD 50 Billion by 2034 | DelveInsight

LAS VEGAS, July 6, 2026, 10:46 GMT-04

DELVEINSIGHT

Read full article →

Fuchs Endothelial Corneal Dystrophy Market Forecast Highlights Significant Growth During the Forecast Period (2026-2036), Owing to the Expanding Treatment Landscape and Increasing Patient Pool | DelveInsight

LAS VEGAS, July 6, 2026, 10:31 GMT-04

DELVEINSIGHT

Read full article →

World's First International Patient Begins Treatment with Newly Approved Solid Tumor CAR-T Therapy at Jiahui International Cancer Center

SHANGHAI, July 6, 2026, 05:10 GMT-04

Jiahui-Health-CAR-T

Read full article →

MRX1 Successfully Delivered to Clinical Trial Site

LONDON, July 6, 2026, 03:00 GMT-04

Ananda-Pharma

Read full article →

SheMed Launches Oral Wegovy in the UK

LONDON, July 3, 2026, 08:21 GMT-04

SheMed-oral-wegovy-UK

Read full article →

Global DNA Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight

LAS VEGAS, July 2, 2026, 10:46 GMT-04

DELVEINSIGHT-BUSINESS

Read full article →

Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight

LAS VEGAS, July 2, 2026, 10:31 GMT-04

DELVEINSIGHT-Health

Read full article →

Label Identification Technologies Market worth $2.87 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., July 2, 2026, 10:30 GMT-04

MARKETSANDMARKETS

Read full article →

Bredehorst Clinic Medical Management, Germany's Leading Healthcare Procurement Specialist, partners with Sigla

DÜSSELDORF, Germany, July 1, 2026, 11:30 GMT-04

Sigla-Bredehorst

Read full article →

Gastroesophageal Reflux Disease (GERD) Device Market to Reach USD 1.9 Billion by 2036 as Advanced Reflux Diagnostics and Minimally Invasive Procedures Improve Treatment Outcomes

NEWARK, Del., July 1, 2026, 11:19 GMT-04

FMI-GERD-device-mkt

Read full article →

Global Oncology-Based In-Vivo CRO Market to Accelerate Substantially at a CAGR of ~8% by 2034 | DelveInsight

LAS VEGAS, July 1, 2026, 10:46 GMT-04

DELVEINSIGHT

Read full article →

High-Grade Glioma Market Witnesses Strong Momentum During the Forecast Period (2026-2036) with Increasing Clinical Activity and Drug Development | DelveInsight

LAS VEGAS, July 1, 2026, 10:31 GMT-04

DELVEINSIGHT-health

Read full article →

Hansa Biopharma announces closing of €115 million licensing transaction with SERB Pharmaceuticals for Idefirix in Europe and MENA

LUND, Sweden, July 1, 2026, 09:24 GMT-04

HANSA-BIOPHARMA-SERB

Read full article →